Maximizing Outcomes in Relapsed/Refractory Multiple Myeloma: Tailoring Bispecific Antibody Approaches : Episode 2

Patient Education: Preparing Patients for Bispecific Treatment in R/R MM

December 23, 2024

By Meera Mohan, MD
Areyl Goff, APNP

Opinion

Video

EP: 1.John’s Journey with R/R MM

Now Viewing

EP: 2.Patient Education: Preparing Patients for Bispecific Treatment in R/R MM

EP: 3.Managing and Monitoring Infections and Neurological Toxicities in Patients Receiving Bispecific Therapies

EP: 4.Handling Dose Modifications and Treatment Interruptions Due to AEs With Bispecifics

EP: 5.Multidisciplinary Approaches to Managing AEs with Bispecifics

EP: 6.Eva’s Treatment Journey with R/R MM

EP: 7.Referring Patients on Bispecific Therapy: Initial Steps

EP: 8.Referral Process: Best Practices for Clear Communication

EP: 9.Referral Process With Bispecifics: Challenges and Support

Video content above is prompted by the following:

1. How do you approach patient education regarding potential adverse events associated with talquetamab and other bispecific therapies?

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!

Latest Conference Coverage

Safety Management With Amivantamab Plus Lazertinib in NSCLC

Tepotinib Shows Manageable Safety in MET Exon 14+ NSCLC

Adverse Events of Menin Inhibitors in AML: What Nurses Should Know

Ivonescimab/Chemo Ups PFS After Third-Generation TKI in EGFR+ NSCLC

View More Latest Conference Coverage

Do Not Sell My Information

Contact Info

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

609-716-7777